Patent ID: 7265111
Filing Date: 2007-09-04
Classification: A61P,C07H

Abstract:
1. A compound according to formula (I) wherein: W is N or N→O; Q is CH R X is selected from the group consisting of wherein n and p are independently 0, 1, 2, or 3, provided that n+p is at least 1; and unsubstituted and at least monosubstituted C E is O or S; Y is selected from the group consisting of hydrogen; and unsubstituted and at least monosubstituted C T is a residue selected from the group consisting of C R A is hydrogen, C B ist hydrogen, C R′ and R″ are independently selected from the group consisting of hydrogen, C when A and B are OR′ and OR″, respectively, R′ and R″ together may form a substituent selected from the group consisting of R R heterocyclyl is a 4 to 10-membered, mono- or bicyclic heterocycle containing one or more heteroatoms selected from the group consisting of N, O and S; aryl is phenyl, indan-1-yl, indan-2-yl, naphth-1-yl or naphth-2-yl; or a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable prodrug thereof, or an N-oxide thereof.